Skip to Content

'
Donald A. Podoloff, M.D., FACR

Present Title & Affiliation

Primary Appointment

Professor, Department of Nuclear Medicine, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
Director, Clinical/Translational Research, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
Medical Director, Center for Advanced Biomedical Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Professor, Department of Diagnostic Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
Professor, Clinical Systems Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX

Bio Statement

Dr. Podoloff is a Fellow of the American College of Nuclear Medicine (FACNM), the American College of Nuclear Physicians (FACNP) and the American College of Radiology (FACR). Dr. Podoloff began his academic career at the University of Texas M.D. Anderson Cancer Center in 1986 and for the prior eleven years was in the private practice of nuclear medicine in Houston, Texas.   He has published over 180 articles/abstracts and is known as an expert nationally and internationally in nuclear oncology. His special area of research interest has been the diagnosis and therapy of Non-Hodgkins Lymphoma.

Education & Training

Degree-Granting Education

1964 State University of New York, Downstate Medical Center, Brooklyn, NY, MD, Medicine
1959 New York University, College of Arts and Sciences, Heights, NY, BA, w/Honors, Chemistry

Postgraduate Training

1/1970-1/1973 Diagnostic Radiology, Lackland Air Force Base, San Antonio, TX
1/1967-1/1968 Chief Resident, Beth Israel Medical Center, New York, NY
1/1965-1/1967 Internal Medicine, Beth Israel Medical Center, New York, NY
1/1964-1/1965 Rotating Internship, Beth Israel Medical Center, New York, NY

Board Certifications

12/1975 American Board of Nuclear Medicine
6/1975 American Board of Radiology, Nuclear Radiology
12/1973 American Board of Radiology
10/1969 American Board of Internal Medicine

Experience/Service

Administrative Appointments/Responsibilities

Division Head, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 9/2001-9/2010
Associate Medical Director, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 9/2001-8/2010

Institutional Committee Activities

Member, eResearch Committee, 2/2011-present
Member, Molecular Testing Evaluation Committee, 9/2010-present
Member, Diagnostic Imaging Executive Committee, 2010-present
Member, Clinical Research Program Steering Team, 10/2009-present
Member, Faculty Mentoring Advisory Committee, 2009-present
Chairman, Radiation Safety Committee, 2002-present
Member, Medical Board, 1997-present
Member, Research Committee, 1993-present
Member, Professional Liability Committee, 1992-present

Honors and Awards

2010 Distinguished Service Award, American Board of Radiology
2009-2013 Top Doctors in Houston
2006-2012 America's Top Doctors for Cancer
2006 America's Top Radiologists
2004-2013 America's Top Doctors

Professional Memberships

ACGME, Chicago, IL
Residency Review Committee - Nuclear Medicine, 9/2009-8/2011
American Board of Radiology, Louisville, KY
Examiner, 1995-present
American College of Nuclear Medicine, Hazleton, PA
Member, Committee on Human Resources (Commission on Nuclear Medicine), 2000-2001
Corporate Committee, 1988-present
American College of Nuclear Physicians, Reston, VA
Delegate, State of Texas House of Delegates, 1992-present
American College of Radiology, Atlanta, GA
Member, Task Force on Continuing Competence, Expert Review Panel for Nuclear Radiology, 1997-present
Radiation Therapy Oncology Group Modality Committee, 1995-present
National Comprehensive Cancer Network, Ft. Washington, PA
Specialized Imaging Research Consortium Advisory Group, 2009-present
NCCN Task Force, 2006-present
Society of Nuclear Medicine, Reston, VA
Member, Committee on Coding and Reimbursement, Society of Nuclear Medicine, 1996-present
Texas Medical Association, Austin, TX
Member, Specialty Committee, 1990-present
Texas Radiological Society, Austin, TX
Member, Advisory Board, 1993-present

Selected Publications

Peer-Reviewed Original Research Articles

1. Bhosale P, Iyer R, Jhingran A, Podoloff D. PET imaging in gynocologic malignancies other than ovarian and cervical cancer. PET Clinics 5(4):463-586, 10/2010.
2. Tu SM, Lin SH, Podoloff DA, Logothetis CJ. Multimodality therapy: Bone-targeted radioisotope therapy of prostate cancer. Clin Adv Hematol Oncol 8(5):341-51, 5/2010. PMID: 20551894.
3. Schechter NR, Erwin WD, Yang DJ, Kim EE, Munden RF, Forster K, Taing LC, Cox JD, Macapinlac HA, Podoloff DA. Radiation dosimetry and biodistribution of (99m)Tc-ethylene dicysteine-deoxyglucose in patients with non-small-cell lung cancer. Eur J Nucl Med Mol Imaging 36(10):1583-91, 10/2009. e-Pub 4/2009. PMCID: PMC2758190.
4. Woodman SE, Trent JC, Stemke-Hale K, Lazar AJ, Pricl S, Pavan GM, Fermeglia M, Gopal YN, Yang D, Podoloff DA, Ivan D, Kim KB, Papadopoulos N, Hwu P, Mills GB, Davies MA. Activity of dasatinib against L576P KIT mutant melanoma: molecular, cellular, and clinical correlates. Mol Cancer Ther 8(8):2079-85, 8/2009. e-Pub 8/2009. PMID: 19671763.
5. Ueno NT, de Souza JA, Booser D, Nakayama K, Madewell J, Wendt RE, Hortobagyi GN, Podoloff D, Champlin RE. Pilot study of targeted skeletal radiation therapy for bone-only metastatic breast cancer. Clin Breast Cancer 9(3):173-7, 8/2009. PMID: 19661041.
6. Booser D, Kazu N, Hortobagyi G, Wendt R III, Podoloff DA, Madewell JE, Champlin RE. Pilot study of targeted skeletal radiotherapy for bone-only metastatic breast cancer. Clinical Breast Cancer 9(3):173-7, 8/2009.
7. Podoloff DA, Ball DW, Ben-Josef E, Benson AB, Cohen SJ, Coleman RE, Delbeke D, Ho M, Ilson DH, Kalemkerian GP, Lee RJ, Loeffler JS, Macapinlac HA, Morgan RJ, Siegel BA, Singhal S, Tyler DS, Wong RJ. NCCN task force: clinical utility of PET in a variety of tumor types. J Natl Compr Canc Netw 7 Suppl 2:S1-26, 6/2009. PMID: 19555588.
8. Podoloff DA. PET/CT and occult primary tumors. J Natl Compr Canc Netw 7(3):239-44, 3/2009. PMID: 19401059.
9. Boonsirikamchai P, Podoloff DA, Choi H. Imaging of gastrointestinal stromal tumors and assessment of benefit from systemic therapy. Hematol Oncol Clin North Am 23(1):35-48, vii, 2/2009. PMID: 19248969.
10. Choi H, Charnsangavej C, Faria SC, Macapinlac HA, Burgess MA, Patel SR, Chen LL, Podoloff DA, Benjamin RS. Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria. J Clin Oncol 25(13):1753 - 1759, 5/2007. PMID: 17470865.
11. Podoloff DA, Advani RH, Allred C, Benson AB, Brown E, Burstein HJ, Carlson RW, Coleman RE, Czuczman MS, Delbeke D, Edge SB, Ettinger DS, Grannis FW, Hillner BE, Hoffman JM, Kiel K, Komaki R, Larson SM, Mankoff DA, Rosenzweig KE, Skibber JM, Yahalom J, Yu JM, Zelenetz AD. NCCN task force report: positron emission tomography (PET)/computed tomography (CT) scanning in cancer. J Natl Compr Canc Netw 5 Suppl 1:S1-S22; quiz S23-2, 5/2007. PMID: 17509259.
12. Christoforidou AV, Saliba RM, Williams P, Qazilbash M, Roden L, Aleman A, Weber D, Mendoza F, Podoloff D, Wendt R, Breitz H, Alexanian R, Champlin R, Giralt S. Results of a retrospective single institution analysis of targeted skeletal radiotherapy with (166)Holmium-DOTMP as conditioning regimen for autologous stem cell transplant for patients with multiple myeloma. Impact on transplant outcomes. Biol Blood Marrow Transplant 13(5):543-9, 5/2007. PMID: 17448913.
13. Benjamin RS, Choi H, Macapinlac HA, Burgess MA, Patel SR, Chen LL, Podoloff DA, Charnsangavej C. We should desist using RECIST, at least in GIST. J Clin Oncol 25(13):1760 - 1764, 5/2007. PMID: 17470866.
14. Bruzzi JF, Truong MT, Marom EM, Mawlawi O, Podoloff DA, Macapinlac HA, Munden RF. Incidental findings on integrated PET/CT that do not accumulate 18F-FDG. AJR Am J Roentgenol 187(4):1116-23, 10/2006. PMID: 16985164.
15. Marom EM, Munden RF, Truong MT, Gladish GW, Podoloff DA, Mawlawi O, Broemeling LD, Bruzzi JF, Macapinlac HA. Interobserver and intraobserver variability of standardized uptake value measurements in non-small-cell lung cancer. J Thorac Imaging 21(3):205-12, 8/2006. PMID: 16915065.
16. Theriault RL, Biermann JS, Brown E, Brufsky A, Demers L, Grewal RK, Guise T, Jackson R, McEnery K, Podoloff D, Ravdin P, Shapiro CL, Smith M, Van Poznak CH. NCCN Task Force Report: Bone Health and Cancer Care. J Natl Compr Canc Netw 4 Suppl 2:S1-20; quiz S21-2, 5/2006. PMID: 16737674.
17. Mawlawi O, Erasmus JJ, Pan T, Cody DD, Campbell R, Lonn AH, Kohlmyer S, Macapinlac HA, Podoloff DA. Truncation artifact on PET/CT: impact on measurements of activity concentration and assessment of a correction algorithm. AJR Am J Roentgenol 186(5):1458-67, 5/2006. PMID: 16632745.
18. Mawlawi O, Erasmus JJ, Munden RF, Pan T, Knight AE, Macapinlac HA, Podoloff DA, Chasen M. Quantifying the effect of IV contrast media on integrated PET/CT: clinical evaluation. AJR Am J Roentgenol 186(2):308-19, 2/2006. PMID: 16423932.
19. Kazama T, Swanston N, Podoloff DA, Macapinlac HA. Effect of colony-stimulating factor and conventional- or high-dose chemotherapy on FDG uptake in bone marrow. Eur J Nucl Med Mol Imaging 32(12):1406-11, 12/2005. PMID: 16133379.
20. Phongkitkarun S, Varavithya V, Kazama T, Faria SC, Mar MV, Podoloff DA, Macapinlac HA. Lymphomatous involvement of gastrointestinal tract: evaluation by positron emission tomography with (18)F-fluorodeoxyglucose. World J Gastroenterol 11(46):7284-9, 12/2005. PMID: 16437629.
21. Tu SM, Kim J, Pagliaro LC, Vakar-Lopez F, Wong FC, Wen S, General R, Podoloff DA, Lin SH, Logothetis CJ. Therapy tolerance in selected patients with androgen-independent prostate cancer following strontium-89 combined with chemotherapy. J Clin Oncol 23(31):7904-10, 11/2005. PMID: 16258090.
22. Lyman GH, Giuliano AE, Somerfield MR, Benson AB, Bodurka DC, Burstein HJ, Cochran AJ, Cody HS, Edge SB, Galper S, Hayman JA, Kim TY, Perkins CL, Podoloff DA, Sivasubramaniam VH, Turner RR, Wahl R, Weaver DL, Wolff AC, Winer EP, Winer EP. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23(30):7703-20, 10/2005. PMID: 16157938.
23. Yi JG, Marom EM, Munden RF, Truong MT, Macapinlac HA, Gladish GW, Sabloff BS, Podoloff DA. Focal uptake of fluorodeoxyglucose by the thyroid in patients undergoing initial disease staging with combined PET/CT for non-small cell lung cancer. Radiology 236(1):271-5, 7/2005. PMID: 15987980.
24. Erasmus JJ, Truong MT, Smythe WR, Munden RF, Marom EM, Rice DC, Vaporciyan AA, Walsh GL, Sabloff BS, Broemeling LD, Stevens CW, Pisters KM, Podoloff DA, Macapinlac HA. Integrated computed tomography-positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: staging implications. J Thorac Cardiovasc Surg 129(6):1364-70, 6/2005. PMID: 15942579.
25. Horning SJ, Younes A, Jain V, Kroll S, Lucas J, Podoloff D, Goris M. Efficacy and safety of tositumomab and iodine-131 tositumomab (Bexxar) in B-cell lymphoma, progressive after rituximab. J Clin Oncol 23(4):712-9, 2/1/2005. PMID: 15613695.
26. Sasaki R, Komaki R, Macapinlac H, Erasmus J, Allen P, Forster K, Putnam JB, Herbst RS, Moran CA, Podoloff DA, Roth JA, Cox JD. [18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer. J Clin Oncol 23(6):1136-43, 2/2005. PMID: 15718309.
27. Gayed IW, Kim EE, Broussard WF, Evans D, Lee J, Broemeling LD, Ochoa BB, Moxley DM, Erwin WD, Podoloff DA. The value of 99mTc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia. J Nucl Med 46(2):248-52, 2/2005. PMID: 15695783.

Book Chapters

1. Podoloff DA, Macapinlac HA. PET and PET/CT in management of the lymphomas. In: Radiol Clin North Am. 45, 4. Ed(s) Barton Dudlick. W.B. Saunders Company: Philadelphia, Pennsylvania, 689, 2007. ISBN: 17706533.

Last updated: 9/11/2013